Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Breast 1

Conditions

Prostatic Neoplasms 10Wilms Tumor 9Leukemia, Myeloid, Acute 9Osteosarcoma 8Neuroblastoma 8Neoplasm Metastasis 8Multiple Myeloma 8Lung Neoplasms 8Glioma 8Sarcoma 7Rhabdoid Tumor 7Lymphoma, Non-Hodgkin 7Hepatoblastoma 7Carcinoma, Hepatocellular 7Rhabdomyosarcoma 6Neuroectodermal Tumors, Primitive, Peripheral 6Myelodysplastic Syndromes 6Medulloblastoma 6Lymphoma 6Histiocytosis, Langerhans-Cell 6Ependymoma 6Colorectal Neoplasms 6Breast Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Melanoma 5Central Nervous System Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Sarcoma, Ewing 4Ovarian Neoplasms 4Endometrial Neoplasms 4

Interventions

Magnetic Resonance Spectroscopy 3Steroids 2Specimen Handling 2Hormones 2Cyclin-Dependent Kinase Inhibitor p18 2Cyclin-Dependent Kinase Inhibitor p16 2Biopsy 2trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1taxane 1radium Ra 223 dichloride 1pertuzumab 1abemaciclib 1X-Rays 1Trastuzumab 1Taxoids 1Taxes 1Radiotherapy 1Radiosurgery 1Radiation 1Photons 1Paclitaxel 1PF-05280014 1Ontruzant 1Ogivri 1Mastectomy, Simple 1Mastectomy, Segmental 1High-Energy Shock Waves 1Capecitabine 1CT-P6 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anatomic Stage IV Breast Cancer AJCC v8 × X-Rays × 90 days × Clear all
NCT04090398 2026-05-13

Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones

National Cancer Institute (NCI)

Phase 2 Active not recruiting
70 enrolled
BreastOther neoplasm

Anatomic Stage IV Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡